The Business Research Company offers Biologics Market By Types,By Trends, By Regions And By Key Players - Global Forecast To 2021 to its research database.

LONDON, GREATER LONDON, UK, June 10, 2019 /EINPresswire.com/ -- The global market for biologics is expected to reach a value of nearly above $350 billion by 2021, having grown at an annual rate of above 10% since 2018.

According to The Business Research Company, 52% of the top 100 pharma products’ sales value will come from biologics as established chemical pharmaceuticals drop off the patent cliff and new breakthrough biologics are approved. All three of the market’s major segments, monoclonal antibodies, therapeutic proteins and vaccines, are growing at close to the overall market rate.

Metabolic disorders are the largest therapeutic treatment area of the global biologics industry, followed by cancer, cardiovascular diseases and immunological diseases. North America is the largest regional market for these drugs and also the fastest-growing, though Asia Pacific is growing almost as fast.

The biologics industry comprises companies manufacturing biological products. Biological products include a wide range of products such as vaccines, allergenics, somatic cells, tissues, and recombinant therapeutic proteins. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. These products are isolated from natural sources such as human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies. Specifically, most biologic medicines are developed using recombinant DNA (rDNA) technology.

Request For A Free Sample For The Global Biologics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=792&type=smp

The size of the biologics market is driven by the critical nature of the diseases treated, the drugs’ ability to provide effective treatments for conditions that have been effectively untreatable by traditional drugs, their patented status and the marketing power of the major pharmaceutical companies which are involved in their development. The market is influenced by factors such as regional demographics, initiatives by the governments supporting the market, technological advances, criticality in the manufacturing process and the increasing penetration of biosimilars. The number of biosimilars being approved is on the rise and is likely to affect the overall growth of the biologics market by expanding the market, but also by reducing average pricing. Currently, the proportion of biosimilars to biologics sold is low in the EU (1%) and the USA (4%), but higher in Asia Pacific, at almost 13% for India and 19% for Japan.

Read More On The Report For The Global Biologics Market At:
https://www.thebusinessresearchcompany.com/report/biologics-market

The top players in the biologics market include Johnson & Johnson F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, AbbVie.

Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions And By Key Players - Global Forecast To 2021 is one of a series of new reports from The Business Research Company that provides biologics market overviews, analyzes and forecasts biologics market size and growth for the global biologics market, biologics market share, biologics market players, biologics market size, biologics market segments and geographies, biologics market trends, biologics market drivers and biologics market restraints, biologics market’s leading competitors’ revenues, profiles and market shares. The biologics market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More
Read Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions And By Key Players - Global Forecast To 2021 from The Business Research Company for information on the following:

Markets Covered: global biologics market and, monoclonal antibodies, therapeutic proteins and vaccines

Data Segmentations: biologics market size, global and by country; historic and forecast size, and growth rates for the world, 7 regions and 12 countries

Biologics Market Organizations Covered: Johnson & Johnson F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, AbbVie

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Time Series: Five years historic (2014-18) and forecast (2018-21).

Other Information And Analyses: PESTEL analysis, biologics market customer information, biologics market

product/service analysis – product examples, biologics market trends and opportunities, drivers and restraints, key mergers and acquisitions, global biologics market in 2019 - countries offering most new opportunities

Sourcing and Referencing: Data and analysis throughout the report are sourced using endnotes.

Strategies For Participants In The Biologics Industry: The report explains a number of strategies for companies in the biologics market, based on industry trends and company analysis.

Opportunities For Companies In The Biologics Sector: The report reveals where the global biologics industry will put on most $ sales up to 2022.

Interested to know more about The Business Research Company?
The Business Research Company has published over 300 industry reports, covering over 2400 market segments and 56 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. Here is a list of reports from The Business Research Company similar to Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions And By Key Players - Global Forecast To 2021:

Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
Anti-Infective Drugs Market By Type Of Product (Antibiotics, Antivirals, Antifungals And Others (Including Anthelminthic And Antiprotozoal Drugs)), Opportunities And Strategies – Global Forecast To 2022

Healthcare Services Market Segment By Type (Hospitals And Clinics, Physicians, Nursing Care, Dental Services, Laboratory Services, Ambulance Services And Others), By End User Gender, By Geography – Global Forecast To 2022

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn